Page last updated: 2024-10-23

bisacodyl and Kidney Failure, Chronic

bisacodyl has been researched along with Kidney Failure, Chronic in 1 studies

Bisacodyl: A diphenylmethane stimulant laxative used for the treatment of CONSTIPATION and for bowel evacuation. (From Martindale, The Extra Pharmacopoeia, 30th ed, p871)

Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.

Research Excerpts

ExcerptRelevanceReference
"Bisacodyl treatment had no effect on plasma K+ concentrations in control subjects, but significantly decreased the mean interdialytic plasma K+ concentration (from 5."1.32Dietary potassium and laxatives as regulators of colonic potassium secretion in end-stage renal disease. ( Mathialahan, T; Sandle, GI, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mathialahan, T1
Sandle, GI1

Other Studies

1 other study available for bisacodyl and Kidney Failure, Chronic

ArticleYear
Dietary potassium and laxatives as regulators of colonic potassium secretion in end-stage renal disease.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2003, Volume: 18, Issue:2

    Topics: Adult; Aged; Bisacodyl; Case-Control Studies; Cathartics; Colon; Fasting; Female; Gastrointestinal A

2003